Archive R Shretta

Costing the Supply Chain for Delivery of ACTs and RDTs in the Public Sector in Benin and Kenya

Shretta R, Johnson B, Smith L, Doumbia S, de Savigny D, Anupindi R, Yadav P. Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya. Malaria Journal. 2015; 14:57. Read the full article

, , , , , , , , , , , , ,

Estimating the In-Country Distribution Costs of Malaria Commodities in Benin and Kenya

This report estimates the cost of the Kenyan and Beninese distribution networks for artemisininbased combination therapies (ACTs) and rapid diagnostic tests (RDTs) in the public sector. Based on this work, we created an extrapolative model to allow donors and country budget planners to quickly and effectively estimate distribution costs for country roadmaps. This model is … Read more

, , , , , , , , , , ,

Guide for Malaria Commodities Logistic Management System

Many developing countries are beneficiaries of donations for implementing their malaria programs. Global initiatives and donors, including USAID/PMI; Global Fund to Fight AIDS, Tuberculosis and Malaria; Roll Back Malaria (RBM); and the Bill & Melinda Gates Foundation, expect that the resources they provide reach the affected population and are managed prudently and that reports are … Read more

, , , , , , , ,

Feasibility of Introducing ACTs and RDTs in Private Sector Pharmacies and Medicine Shops in Montserrado County, Liberia: A Qualitative Study

Liberia’s National Malaria Control Program (NMCP) requested that SIAPS undertake a study to explore the feasibility and willingness of private sector pharmacies and medicine shops in the Greater Monrovia and rural Montserrado areas of Montserrado County, Liberia, to perform RDTs and to select appropriate products to recommend for malaria treatment for customers to purchase.

, , , , , , , , , , , , , , ,

Stabilizing Supply and Avoiding National-Level Stock Outs of ACTs in an Era of Wide ACT Scale-Up

Download The demand for artemisinin-based combination therapy (ACT) has grown sharply since its recommendation by the World Health Organization in 2002. However, the rates at which endemic countries have scaled-up their use have varied, resulting in a cycle of volatile supply and demand. Although various short-term solutions have alleviated country-level stockouts, without robust mechanisms to … Read more

, , , ,